Stay updated with breaking news from Interdisciplinary Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have created a new nanometer-scale proximity labeling system that targets histidine residues quickly, providing a new chemical tool in...
DST funded start-up's ELISA test to better estimate COVID 19 antibody concentration ANI | Updated: May 22, 2021 11:00 IST The ministry in an official statement said that it was a Bangalore-based start-up that "developed a novel, point-of-care Electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID 19 in clinical samples." The handheld device provides the results within five minutes. "PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development (SID), Indian Institute of S...
Share New Delhi: A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID 19 in clinical samples. PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a very significant breakthrough to develop the first of its kind, semi-quantitative Electrochemical ELISA test for COVID-19 IgM and IgG antibodies. While Qualitative semiquantitative analysis gives an approximate estimation of their co...
New Delhi [India], May 22 (ANI): A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test to estimate accurate antibody concentration of COVID-19 in clinical samples, informed the Union Science and Technology Ministry on Saturday.
PathShodh received the license to manufacture the test for sale from the Central Drugs Standard Control Organisation, after careful examination and validation from the Translational Health Science and Technology Institute, as per the requirements of the Indian Council of Medical Research (ICMR).